Marinus Pharmaceuticals (MRNS) PT Lowered to $20 at RBC Capital

August 11, 2023 6:09 AM EDT Send to a Friend

RBC Capital analyst Brian Abrahams ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Marinus Pharmaceuticals (MRNS) PT Lowered to $20 at RBC Capital

Member Login

Free News Feed